Medical Tubing and Extrusion

Medical tubing and extrusion technologies

Cordis

Cordis reports positive 2-year data for drug-eluting balloon

By

Cordis today announced positive 24-month results from a study evaluating its Selution SLR drug-eluting balloon (DEB). Selution SLR offers endovascular therapy for de novo and non-stented restenotic lesions in the superficial femoral artery (SFA) and the popliteal artery (PA). Cordis acquired the DEB technology from MedAlliance for $1.135 billion … [Read more...] about Cordis reports positive 2-year data for drug-eluting balloon

The worst catheter-based device recalls of 2023

By

The U.S. saw seven severe catheter-based device recalls in 2023, according to the FDA's medical device recall database. The agency in 2023 tagged 61 medical device recalls as Class I — the most serious level. For comparison, the FDA recalled 60 devices in 2022, of which four were related to catheter-based devices. Last year, the most serious … [Read more...] about The worst catheter-based device recalls of 2023

Cordis applauds Medicare expansion for carotid stenting

By

Cordis announced today that it supports a new expanded coverage decision from the Centers for Medicare & Medicaid Services (CMS). The expanded CMS coverage widens access to minimally invasive endovascular carotid therapy for patients with carotid artery disease. Cordis develops the Precise Pro Rx carotid stent system for this therapy. In a … [Read more...] about Cordis applauds Medicare expansion for carotid stenting

Cordis acquires drug-eluting balloon maker MedAlliance for up to $1.135B

By

MedAlliance announced today that Cordis acquired it for a total consideration that could reach up to $1.135 billion. The companies initially announced the planned deal in October of last year. Cordis, which develops interventional cardiovascular and endovascular technologies, made a $35 million investment last year. Its upfront closing … [Read more...] about Cordis acquires drug-eluting balloon maker MedAlliance for up to $1.135B

Cordis among those investing $15M in Endovascular Engineering

By

Endovascular Engineering today announced the closing of a $15 million Series A1 financing co-led by Santé Ventures and Cordis. The Menlo Park, California–based startup is also called E2. It's focused on developing advanced mechanical thrombectomy technology. "With the close of this funding, we will continue the journey from concept to … [Read more...] about Cordis among those investing $15M in Endovascular Engineering

Cordis names new CFO

By

Cordis today announced that it has appointed Christopher Scully as chief financial officer. Scully will be responsible for leading the interventional cardiovascular technology company’s financial and IT functions to accelerate Cordis’s growth. Prior to joining the company, Scully was executive VP and CFO for PPD. Get the full story on our … [Read more...] about Cordis names new CFO

Cordis recalls some Smart Flex vascular stent systems

By

Cordis recently issued a warning letter regarding an issue with its Smart Flex vascular stent system. Santa Clara, California-based Cordis's field safety correction action informs users that some of its Smart Flex vascular stents have the potential for distal tip dislodgment or separation due to inadequate adhesive application. The recall … [Read more...] about Cordis recalls some Smart Flex vascular stent systems

FDA says Cordis carotid artery stent recall is serious

By

The FDA has classified Cordis‘ recall of its Precise Pro Rx carotid system as Class I, the most serious kind of recall. Cordis in February recalled certain lots of its Precise Pro RX carotid stent systems because of a risk of separation of the atraumatic distal tip of the sheathed delivery system in patients. Get the full story at our sister … [Read more...] about FDA says Cordis carotid artery stent recall is serious